查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1612617

血型分型市場：按技術、測試類型、產品類型和最終用戶分類 - 2025-2030 年全球預測

Blood Group Typing Market by Techniques (Assay-Based Techniques, Massively Parallel Sequencing, Microarray), Test Type (ABO Blood Tests, Antibody Screening, Antigen Typing), Product, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年血型鑑定市場價值為33.7億美元，預計到2024年將達到36.3億美元，複合年成長率為7.82%，到2030年預計將達到57.2億美元。

血型是確定個別血型和Rh因子的重要診斷過程，對於安全輸血、器官移植和產前護理至關重要。這一步驟對於急診醫學、常規醫療保健和研究至關重要，以確保適合預防潛在危及生命的免疫反應。由於血液安全意識的提高、外科手術數量的增加以及慢性病的流行，血型市場正在擴大，推動了對可靠血液檢測的需求。自動和數位打字系統等重大技術進步提高了速度和準確性，這是一個關鍵促進因素。此外，新興國家醫療保健基礎設施投資的增加也帶來了市場擴張的機會。人口老化和需要輸血的疾病增加也增加了市場需求。然而，市場面臨先進打字系統的高成本、監管障礙以及對熟練技術人員的需求等挑戰。透過開發具有成本效益、易於使用的技術和強大的培訓計劃來解決這些限制可以促進進一步的成長。就地檢驗設備、與人工智慧整合進行預測分析以及個人化醫療解決方案等創新代表了有前景的研究領域。此外，加強研發力度以創造通用血液替代品可能會徹底改變該領域。與醫療保健提供者合作，透過教育宣傳活動提高意識也可能推動市場成長。相反，挑戰包括低收入地區的意識低落、潛在的漏報以及技術複雜性。儘管存在這些障礙，技術創新和擴大醫療保健服務正在推動市場成長。對研發的策略性投資、專注於技術整合的夥伴關係以及利用新興市場的潛力將是利用血型定型機會的關鍵。

主要市場統計
基準年[2023] 33.7億美元
預計年份 [2024] 36.3億美元
預測年份 [2030] 57.2億美元
複合年成長率（%） 7.82%

市場動態：揭示快速發展的血型分型市場的關鍵市場洞察

供需的動態交互作用正在改變血型市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 交通事故、緊急狀況和創傷的增加
    • 法醫學中擴大採用血型分型
    • 嚴格的輸血監管標準
  • 市場限制因素
    • 缺乏意識和熟練的專業人員
  • 市場機會
    • 血型分型系統的進步與發展
    • 增加血型分型的研發活動與產品創新
  • 市場挑戰
    • 傳輸相關風險

波特五力：駕馭血型分型市場的策略工具

波特的五力架構是了解血型分型市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解血型分型市場的外部影響

外部宏觀環境因素對血型定型市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解血型定型市場的競爭格局

對血型分型市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣血型分型市場供應商績效評估

FPNV定位矩陣是評估血型分型市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製血型分型市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對血型分型市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 交通事故、緊急狀況和創傷的增加
      • 法醫學中擴大採用血型分型
      • 嚴格的輸血監管標準
    • 抑制因素
      • 缺乏意識和熟練的專業人員
    • 機會
      • 血型分型系統的進步與發展
      • 加強血型分型研發活動與產品創新
    • 任務
      • 與傳染病相關的風險
  • 市場區隔分析
    • 技術：擴大採用基於分析的大規模平行定序技術
    • 測試類型：快速出現的ABO血型測試和檢測抗原的人類白血球抗原分型測試
    • 產品：血型鑑定服務中耗材和儀器的關鍵使用
    • 最終使用者：臨床實驗室和醫院血型服務的新用途
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 血型定型市場技術

  • 基於分析的技術
  • 大規模平行定定序
  • 微陣列

第7章依測試類型分類的血型分型市場

  • ABO血型檢查
  • 抗體篩檢
  • 抗原分型
  • 交叉配系列
  • 人類白血球抗原分型

第8章血型定型市場：依產品

  • 消耗品
  • 裝置
  • 服務

第 9 章 血型定型市場：依最終使用者分類

  • 血庫
  • 臨床實驗室
  • 醫院

第10章美洲血型鑑定市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區血型分型市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲血型鑑定市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 我的個人健康銀行與 Eldon Biologicals A/S 合作，提供結合 POC 血型測試的創新醫療保健解決方案
    • Metropolis Healthcare 開始測試 HSCT 和固態器官移植
    • NHSBT 研究人員發現新血型系統
  • 戰略分析和建議

公司名單

  • Agena Bioscience, Inc.
  • Atlas Medical GmbH
  • AXO Science SAS
  • BAG Health Care GmbH
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc
  • Biorex Diagnostics
  • Cardinal Health
  • Genome Diagnostics BV
  • Grifols, SA
  • Hemo bioscience, Inc.
  • Lorne Laboratories Limited
  • Merck KGaA
  • Quotient Suisse SA
  • Rapid Labs Ltd
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-437D459582E9

The Blood Group Typing Market was valued at USD 3.37 billion in 2023, expected to reach USD 3.63 billion in 2024, and is projected to grow at a CAGR of 7.82%, to USD 5.72 billion by 2030.

Blood group typing is a critical diagnostic process that determines an individual's blood type and Rh factor, essential for safe blood transfusions, organ transplants, and prenatal care. This procedure is crucial in medical emergencies, routine healthcare, and research, ensuring compatibility to prevent potentially life-threatening immune responses. The market for blood group typing is expanding due to rising awareness about blood safety, increased surgical procedures, and chronic disease prevalence, which drive the demand for reliable blood testing. Significant technological advancements, such as automated and digital typing systems, enhance speed and accuracy, which are critical growth drivers. Moreover, growing investments in healthcare infrastructure in emerging economies present opportunities for market expansion. The aging population, coupled with increasing cases of disorders requiring blood transfusions, also augments market demand. However, the market faces challenges like high costs of advanced typing systems, regulatory hurdles, and the need for skilled technicians. Addressing these constraints by developing cost-effective, user-friendly technologies and robust training programs could foster further growth. Innovations such as point-of-care testing devices, integration with AI for predictive analytics, and personalized medical solutions represent promising research areas. Additionally, increased R&D efforts towards creating universal blood alternatives could revolutionize the field. Collaborating with healthcare providers to enhance awareness through education campaigns may also promote market growth. Conversely, limited awareness in low-income regions, potential for false negatives, and technical complexities pose challenges. Despite these hurdles, the market is poised for growth, driven by technological innovations and expanding healthcare access. Strategic investments in R&D, partnerships focusing on technological integration, and harnessing emerging market potentials will be key to capitalizing on the opportunities in blood group typing.

KEY MARKET STATISTICS
Base Year [2023] USD 3.37 billion
Estimated Year [2024] USD 3.63 billion
Forecast Year [2030] USD 5.72 billion
CAGR (%) 7.82%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Group Typing Market

The Blood Group Typing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of road accidents, emergencies, and trauma
    • Rising adoption of blood group typing in forensic sciences
    • Strict regulatory standards regarding blood transfusion
  • Market Restraints
    • Lack of awareness and skilled professional
  • Market Opportunities
    • Advancements and developments in the blood group typing systems
    • Increasing R&D activities and product innovations in blood group typing
  • Market Challenges
    • Risk associated with transmissible diseases

Porter's Five Forces: A Strategic Tool for Navigating the Blood Group Typing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Group Typing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Group Typing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Group Typing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Group Typing Market

A detailed market share analysis in the Blood Group Typing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Group Typing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Group Typing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Group Typing Market

A strategic analysis of the Blood Group Typing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Group Typing Market, highlighting leading vendors and their innovative profiles. These include Agena Bioscience, Inc., Atlas Medical GmbH, AXO Science SAS, BAG Health Care GmbH, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc, Biorex Diagnostics, Cardinal Health, Genome Diagnostics B.V., Grifols, S.A., Hemo bioscience, Inc., Lorne Laboratories Limited, Merck KGaA, Quotient Suisse SA, Rapid Labs Ltd, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Blood Group Typing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Techniques, market is studied across Assay-Based Techniques, Massively Parallel Sequencing, and Microarray.
  • Based on Test Type, market is studied across ABO Blood Tests, Antibody Screening, Antigen Typing, Cross-Matching Series, and Human Leukocyte Antigen Typing.
  • Based on Product, market is studied across Consumables, Instruments, and Services.
  • Based on End-User, market is studied across Blood Banks, Clinical Laboratories, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of road accidents, emergencies, and trauma
      • 5.1.1.2. Rising adoption of blood group typing in forensic sciences
      • 5.1.1.3. Strict regulatory standards regarding blood transfusion
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of awareness and skilled professional
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and developments in the blood group typing systems
      • 5.1.3.2. Increasing R&D activities and product innovations in blood group typing
    • 5.1.4. Challenges
      • 5.1.4.1. Risk associated with transmissible diseases
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Techniques: Increasing adoption of assay-based and massively Parallel Sequencing techniques
    • 5.2.2. Test Type: Rapid emergence of ABO blood tests and human leukocyte antigen typing tests to detect the antigens
    • 5.2.3. Product: Significant use of consumables and instruments in blood group typing services
    • 5.2.4. End-User: Emerging use of blood group typing services in clinical laboratories and hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Blood Group Typing Market, by Techniques

  • 6.1. Introduction
  • 6.2. Assay-Based Techniques
  • 6.3. Massively Parallel Sequencing
  • 6.4. Microarray

7. Blood Group Typing Market, by Test Type

  • 7.1. Introduction
  • 7.2. ABO Blood Tests
  • 7.3. Antibody Screening
  • 7.4. Antigen Typing
  • 7.5. Cross-Matching Series
  • 7.6. Human Leukocyte Antigen Typing

8. Blood Group Typing Market, by Product

  • 8.1. Introduction
  • 8.2. Consumables
  • 8.3. Instruments
  • 8.4. Services

9. Blood Group Typing Market, by End-User

  • 9.1. Introduction
  • 9.2. Blood Banks
  • 9.3. Clinical Laboratories
  • 9.4. Hospitals

10. Americas Blood Group Typing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Blood Group Typing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Blood Group Typing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. My Personal Health Bank Joins Forces with Eldon Biologicals A/S for Innovative Healthcare Solutions incorporating POC Blood Typing
    • 13.3.2. Metropolis Healthcare launches test for HSCT & solid organ transplantation
    • 13.3.3. NHSBT Researchers Discover New Blood Group System
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agena Bioscience, Inc.
  • 2. Atlas Medical GmbH
  • 3. AXO Science SAS
  • 4. BAG Health Care GmbH
  • 5. Beckman Coulter, Inc.
  • 6. Bio-Rad Laboratories, Inc
  • 7. Biorex Diagnostics
  • 8. Cardinal Health
  • 9. Genome Diagnostics B.V.
  • 10. Grifols, S.A.
  • 11. Hemo bioscience, Inc.
  • 12. Lorne Laboratories Limited
  • 13. Merck KGaA
  • 14. Quotient Suisse SA
  • 15. Rapid Labs Ltd
  • 16. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. BLOOD GROUP TYPING MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD GROUP TYPING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BLOOD GROUP TYPING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BLOOD GROUP TYPING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BLOOD GROUP TYPING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BLOOD GROUP TYPING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD GROUP TYPING MARKET DYNAMICS
  • TABLE 7. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ASSAY-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY MASSIVELY PARALLEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ABO BLOOD TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANTIBODY SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY ANTIGEN TYPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CROSS-MATCHING SERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HUMAN LEUKOCYTE ANTIGEN TYPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD GROUP TYPING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES BLOOD GROUP TYPING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA BLOOD GROUP TYPING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM BLOOD GROUP TYPING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. BLOOD GROUP TYPING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 194. BLOOD GROUP TYPING MARKET, FPNV POSITIONING MATRIX, 2023